Product Information
VILAZODONE HCL 10 MG TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.7317 per EA under NDC 00480204556. Its NADAC has been published 216 times since Aug 17, 2022.
FDA first approved this application on Sep 30, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00480204556
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
VILAZODONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA208212FDA Approved
9/30/2019
TE Code
AB
On Market Since
6/6/2022
Price Statistics
The NADAC for VILAZODONE HCL 10 MG TABLET has been published 216 times since Aug 17, 2022, and over the history we have for it it has declined 61.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7317 per EA |
|---|---|
| All-time high | $1.9161 (Sep 14, 2022) |
| All-time low | $0.7317 (Sep 23, 2026) |
| 52-week high | $1.0443 |
| 52-week low | $0.7317 |
| Median price | $1.0937 |
| Average price | $1.2059 |
| Largest weekly change | +38.4% (Aug 21, 2024) |
| Weeks tracked | 216 |
| Tracking since | Aug 17, 2022 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Teva Pharmaceuticals USA Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Vilazodone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VILAZODONE HCL 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VILAZODONE HCL 10 MG TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.7317 per EA (NDC 00480204556), effective Sep 30, 2026.
How has the price of VILAZODONE HCL 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for VILAZODONE HCL 10 MG TABLET has declined 61.8%. It has been tracked across 216 weekly CMS publications since Aug 17, 2022.
What are the highest and lowest recorded NADAC prices for VILAZODONE HCL 10 MG TABLET?
Since Aug 17, 2022, the NADAC for VILAZODONE HCL 10 MG TABLET has ranged from a low of $0.7317 (Sep 23, 2026) to a high of $1.9161 (Sep 14, 2022), with a median of $1.0937 per EA.
Are there cheaper alternatives to VILAZODONE HCL 10 MG TABLET?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VILAZODONE HCL 10 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures VILAZODONE HCL 10 MG TABLET?
VILAZODONE HCL 10 MG TABLET (NDC 00480204556) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.